Evaluation of Outcomes with Citalopram for Depression Using Measurement-Based Care in STAR*D: Implications for Clinical Practice
American Journal of Psychiatry, 2006 · paper · Clinical trials
Evaluates citalopram given with measurement-based care to 2,876 real-world outpatients with major depression. Remission rates were 28% (clinician-rated) and 33% (self-report), resembling those in 8-week efficacy trials; several patient characteristics predicted remission.
Checked: PDF from web.archive.org, fetched 5 Oct 2026. Page numbers are those of that PDF.
3 findings
Substance Discussion says "Of participants who responded, 56.0% did so only at or after 8 weeks of treatment" and "Of those who achieved QIDS-SR remission, 40.3% did so only at or after 8 weeks". Figure 3 shows about 35% of responders and about 50% of remitters at week ≥8, the opposite order.
- p. 7 Discussion, para 5
Of participants who responded, 56.0% did so only at or after 8 weeks of treatment.
- p. 7 Discussion, para 5
QIDS-SR remission, 40.3% did so only at or after 8 weeks of
- p. 6 Figure 3; Results, Symptomatic Outcomes
the mean time to remission was 6.7 weeks
- p. 6 Figure 3, Response (N=1,343) bars
Response (N=1,343)
Only the authors can say what is right here.
Judge's note: Bars read from the p6 image for weeks 8/10/12/≥13: response ≈11.5+11.0+4.9+7.6 ≈35%, remission ≈14.5+12.9+10.0+12.9 ≈50%. 56% for responders is also hard to reconcile with a mean time to response of 5.7 weeks (SD 3.5), shorter than the 6.7 weeks to remission. If the week-8 bin included earlier visits, the share at or after 8 weeks could only be smaller. The figures may be swapped or computed with a different cutoff; only the authors can say. This also feeds the abstract's 'substantial portion' statement.
Second check: another model agreed
Report a problem with this finding
Reference or label In Table 3 footnote markers c and d appear swapped. c ("Includes psychiatric hospitalization and suicidal ideation without hospitalization") is attached to "Suicidal ideation (without hospitalization)". d ("Includes hospitalizations for worsening depression, substance abuse, suicidal ideation, and other") is attached to "Any psychiatric serious adverse event".
- p. 7 Table 3, serious adverse events rows
Suicidal ideation (without hospitalization)c
- p. 7 Table 3, footnotes c and d
c Includes psychiatric hospitalization and suicidal ideation without hospitalization.
Judge's note: On the p7 image, superscript c sits on the suicidal-ideation row and d on the 'Any psychiatric serious adverse event' row. Footnote c describes the composite row (55 ≈ 50 hospitalizations + 6 ideation, with overlap). Footnote d describes the psychiatric hospitalization row. A row of ideation without hospitalization cannot include hospitalization.
Second check: another model agreed
Report a problem with this finding
Wording Abstract lists "longer index episodes" among factors "associated with lower HAM-D remission rates", and the Discussion lists "a shorter current episode" among features associated with higher remission. But Table 4 gives episode length ≥24 vs <24 months OR 0.91, p=0.39 (HAM-D) and OR 0.87, p<0.16 (QIDS-SR), and episode length is absent from Table 5.
- p. 1 Abstract, Results
longer index episodes, more concur-rent psychiatric disorders
- p. 9 Discussion
and a shorter current episode
- p. 8 Table 4, Length of episode
0.39
- p. 9 Discussion, right column, top
greater life satis-faction, and a shorter current episode
Only the authors can say what is right here.
Judge's note: Checked the abstract (p1), Table 4 on p8 (Length of episode row: 0.39 and <0.16) and Table 5 on p11 (no episode-length factor in any domain). Methods (p5) define significance as a two-sided p<0.05 from logistic models adjusted for regional center and baseline severity. No other analysis of episode length is reported. Only the crude rates differ (28.4% vs 24.4%). Only the authors can say what analysis supports the claim.
Second check: another model agreed
Report a problem with this finding
10 minor (typos and the like; most checked by the judge only)
Substance Table 4, Agoraphobia No (N=2,508), HAM-D: "728 29.1". 728/2508 = 29.03%, which rounds to 29.0.
- p. 9 Table 4 (continued), Agoraphobia, No (N=2,508), HAM-D columns
728 29.1
Only the authors can say what is right here.
Judge's note: Page 9 image checked. Table 4 footnote a says subjects with missing exit HAM-D were classified as not in remission and that percentages are based on the number of subjects with each baseline characteristic. The HAM-D denominator should therefore be the row N. The neighbouring HAM-D cells all reproduce from the row N: GAD 641/2170 = 29.5, OCD 706/2437 = 29.0, panic 719/2472 = 29.1, agoraphobia Yes 55/335 = 16.4. This cell does not. The gap is 0.1 point, so it is trivial, and only the authors can say whether the count or the percentage is off.
Second check: another model agreed
Report a problem with this finding
Reference or label Figure 3 title "Percent of 2,876 Outpatients With Nonpsychotic Major Depressive Disorder Who Achieved Response or Remission ... by Week of Treatment" does not match the bars. Each series sums to about 100%, so the denominators are the 943 remitters and 1,343 responders, not 2,876.
- p. 6 Figure 3 caption and bars
FIGURE 3. Percent of 2,876 Outpatients With Nonpsychotic Major Depressive Disorder Who Achieved Response or Remission
- p. 6 Figure 3 title
Percent of 2,876 Outpatients With Nonpsychotic Major Depressive Disorder Who Achieved Response or Re-mission
Judge's note: Bar heights read from the p6 image: remission ≈11.4, 19.4, 22.1, 14.5, 12.9, 10.0, 12.9 (sum ≈103); response ≈17.8, 24.5, 22.9, 11.5, 11.0, 4.9, 7.6 (sum ≈100). The Results text describes the figure as the distribution of time to first remission/response among those who achieved it. If 2,876 were the denominator, the series would sum to only about 33% and 47%. The title mislabels the population.
Second check: another model agreed
Report a problem with this finding
Reference or label Table 3 footnote markers look misplaced: footnote c ("Includes psychiatric hospitalization and suicidal ideation without hospitalization") is attached to "Suicidal ideation (without hospitalization)", and footnote d ("Includes hospitalizations for worsening depression, substance abuse, suicidal ideation, and other") to "Any psychiatric serious adverse event". The subcategory counts (3+47+4+50+6) do not sum to Total 103, but that fits patients having more than one type of event.
- p. 7 Table 3, serious adverse events
Any psychiatric serious adverse eventd 55 2.6 2 0.3 57 2.0
- p. 7 Table 3, Total
Total 103 4.9 13 1.6 116 4.0
- p. 7 Table 3, serious adverse events
Psychiatric hospitalization 50 — 2 — 52
Only the authors can say what is right here.
Judge's note: I looked at the Table 3 crop and page 7. The arithmetic part does not hold up as an error. The Results text on p.7 says "116 participants experienced at least one serious adverse effect; most of these patients (88.8% [N=103])...", so Total counts participants, and one participant can fall into several categories. A subcategory sum above the total (110 vs 103; 123 vs 116) is therefore expected. 'Any psychiatric' = 55, which is at most 50+6 = 56, so it is a valid union with one participant having both a psychiatric hospitalization and suicidal ideation. The remission column sums exactly (13). What remains is the footnote placement. The content of footnote c describes the 'Any psychiatric' row, and the content of footnote d describes the 'Psychiatric hospitalization' row, but the markers sit on other rows. Only the authors can confirm the intended placement.
Second check: another model agreed
Report a problem with this finding
Wording Abstract says more concurrent psychiatric disorders "(especially anxiety disorders or drug abuse)" were associated with lower HAM-D remission, but Table 4 gives drug abuse/dependence p <0.06 (HAM-D) and <0.10 (QIDS-SR), and drug abuse is not in Table 5.
- p. 1 Abstract, Results
(especially anxi-ety disorders or drug abuse)
- p. 9 Table 4, Drug abuse/dependence
<0.06
Only the authors can say what is right here.
Judge's note: On the p9 image, Table 4's drug abuse/dependence row shows OR 0.71 with p <0.06 for HAM-D and OR 0.75 with p <0.10 for QIDS-SR. The stated threshold is p<0.05 (p5). Alcohol abuse (<0.04) is the substance-use variable that meets the threshold. The number of comorbid disorders is significant (0.0001), so the main clause holds; only the drug-abuse example is unsupported.
Second check: another model agreed
Report a problem with this finding
Wording The Introduction lists education under "social features", but Table 5 places "Education (reference group=high school but < college)" under "Demographic domain". Table 1 puts education categories under Social domain and education in years under Demographic domain.
- p. 2 Introduction, domain definitions
2) social features (e.g., education, employ-ment status, income, insurance, and marital status)
- p. 11 Table 5, Demographic domain
Education (reference group=high school but < college)
Judge's note: Checked the domain definitions on p2, Table 1 on p4 (text layer) and Table 5 on p11. The stepwise models were run within domains, so which domain education was entered into is left unclear. This is a minor consistency point.
Second check: another model agreed
Report a problem with this finding
Wording Discussion says the model held "even after controlling for both severity and treatment settings", but Methods and the footnotes to Tables 4 and 5 state adjustment for regional center and baseline severity.
- p. 9 Discussion, right column
controlling for both severity and treatment settings
- p. 5 Statistical Analysis
independent of the effect of regional center and baseline depression severity
Only the authors can say what is right here.
Judge's note: I compared the p.9 Discussion with the p.5 Statistical Analysis section ("independent of the effect of regional center and baseline depression severity") and with footnotes b and c of Table 4 (adjusted for regional center and baseline HAM-D or QIDS-SR). In Table 4, 'Setting' (primary vs psychiatric care) is a predictor, not a covariate. 'Treatment settings' therefore misdescribes the adjustment, unless it is meant loosely for regional centers. This is a wording issue.
Second check: another model agreed
Report a problem with this finding
Wording Text says "Findings were almost identical for the HAM-D and the QIDS-SR except that anxious depression and concurrent generalized anxiety disorder were also associated with lower QIDS-SR remission rates". But Table 4 also gives GAD a HAM-D p of <0.05 (OR 0.80, the same as QIDS-SR).
- p. 6 Results, Pretreatment Correlates of Remission
except that anxious depression and concurrent gener-alized anxiety disorder were also associated with lower QIDS-SR remission rates
- p. 9 Table 4, Generalized anxiety disorder, HAM-D p
<0.05
- p. 8 Table 4, Gender / Marital status p values
<0.002
- p. 6 Pretreatment Correlates of Remission
anxious depression and concurrent gener-
Only the authors can say what is right here.
Judge's note: Table 4 on the p9 image: GAD shows HAM-D OR 0.80, p <0.05 and QIDS-SR OR 0.80, p 0.03. Anxious depression is the only listed factor that is significant for QIDS-SR alone (0.67 vs <0.002). Other factors differ the other way: gender is <0.002 vs <0.10 and marital status <0.02 vs <0.23 (p8), and alcohol abuse is <0.04 vs <0.09 (p9). Naming GAD as a QIDS-SR-only finding does not match the table under the stated p<0.05 threshold.
Second check: another model agreed
Report a problem with this finding
Wording Results say lower remission was associated with "being non-Caucasian" (and Discussion: "being Caucasian" with higher remission). But the 'Other' race group has Table 5 OR 1.11/1.04 against Caucasian and Table 4 remission 31.1% vs 29.2%. Footnote d says only Caucasian vs African American differed.
- p. 7 Results, final paragraph (Table 5 description)
non-Caucasian, male, and less educated
- p. 11 Table 5, Race, Other
1.11
- p. 8 Table 4, Race, Other (N=190)
31.1
- p. 9 Discussion, left column
Caucasian, female, better educated, and more highly paid
Judge's note: Checked Table 5 (p11): African American 0.69/0.66, Other 1.11/1.04. Table 4 (p8): Other 59 (31.1%), OR 1.14. Footnote d (p10 text) limits the significant contrast to Caucasian vs African American. The wording generalises that contrast to all non-Caucasians.
Second check: another model agreed
Report a problem with this finding
Wording Discussion: "married or cohabiting patients met criteria for treatment response with greater frequency than single participants". Table 4 reports remission only, by marital categories that do not include cohabitation, and no data on response or dropout by marital status are shown.
- p. 10 Discussion, left column
married or cohabiting patients met criteria for treat-ment response with greater frequency than single par-ticipants
- p. 8 Table 4, Marital status
Never married (N=823)
- p. 10 Discussion
met criteria for treatment response with greater frequency than single par-
- p. 8 Table 4, Marital status
Marital statuse
Only the authors can say what is right here.
Judge's note: I checked Table 4 on p.8 and the Discussion on p.10. Table 4 gives remission by marital status: HAM-D married 31.2% vs never married 24.7%, p<0.02; QIDS-SR p<0.23. The categories are never married, married, divorced and widowed. The paper defines response separately (≥50% QIDS-SR reduction, Figure 3), and no response or attrition results by marital status or living arrangement appear. The preceding sentence says 'remission', so 'response' is probably loose wording. Even so, the cohabitation and dropout statements are not backed by the data presented.
Second check: another model agreed
Report a problem with this finding
Typo Table 4 footnote g: "< college significant different from ≥ college" should read "significantly different".
- p. 10 Table 4, footnote g
< college significant different from ≥ college
Judge's note: The page 10 image shows the word as printed. Every parallel phrase in footnotes d–i reads "significantly different".
Second check: none (judge only)